Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Colon & Rectum (Late Stage^), 2015-2019

All Races (includes Hispanic), Both Sexes, Ages 50+

Sorted by Percentlate
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late ascending
US (SEER+NPCR) 1 64.9 (64.7, 65.2) N/A 72,150 57.1
Idaho 3 65.9 (62.9, 69.1) 21 (14, 33) 373 61.4
Mississippi 6 88.0 (85.4, 90.6) 1 (1, 1) 908 59.9
Pennsylvania 6 72.0 (70.9, 73.1) 9 (6, 16) 3,578 59.7
Missouri 6 71.1 (69.5, 72.7) 16 (7, 17) 1,571 59.5
Tennessee 6 71.3 (69.7, 72.8) 14 (7, 17) 1,687 59.5
North Carolina 6 63.8 (62.6, 65.0) 25 (22, 32) 2,284 59.4
Alaska 6 74.0 (68.4, 80.0) 6 (2, 23) 149 59.1
Indiana 6 73.6 (72.0, 75.2) 8 (3, 14) 1,670 58.8
North Dakota 6 71.6 (66.8, 76.5) 13 (2, 24) 179 58.6
Wisconsin 6 63.8 (62.2, 65.4) 26 (20, 34) 1,341 58.6
Colorado 6 56.6 (55.0, 58.3) 43 (37, 47) 980 58.4
Oregon 6 59.3 (57.5, 61.1) 39 (31, 44) 881 58.3
Illinois 3 73.7 (72.6, 74.9) 7 (4, 12) 3,207 58.2
South Dakota 6 71.8 (67.5, 76.3) 10 (2, 23) 220 58.1
Arkansas 6 77.3 (74.9, 79.7) 2 (2, 8) 834 58.0
Ohio 6 71.2 (70.0, 72.3) 15 (8, 17) 3,042 57.9
Wyoming 6 60.0 (55.2, 65.2) 36 (19, 48) 119 57.8
Montana 6 64.2 (60.7, 67.9) 24 (16, 39) 259 57.7
New Hampshire 6 60.9 (57.9, 64.0) 35 (22, 44) 318 57.7
Michigan 6 63.2 (62.0, 64.4) 27 (23, 34) 2,313 57.4
Washington 5 58.6 (57.2, 60.0) 40 (34, 44) 1,434 57.2
Virginia 6 59.4 (58.1, 60.7) 38 (32, 43) 1,689 57.0
Florida 6 61.9 (61.2, 62.7) 30 (27, 36) 5,362 56.8
Texas 3 65.5 (64.7, 66.3) 23 (19, 26) 5,297 56.7
New Jersey 3 69.0 (67.7, 70.4) 17 (13, 20) 2,190 56.5
Maryland 6 61.2 (59.6, 62.7) 34 (26, 40) 1,253 56.3
Rhode Island 6 57.7 (54.3, 61.2) 42 (28, 49) 225 56.3
Louisiana 3 76.5 (74.5, 78.4) 3 (2, 8) 1,207 56.2
Maine 6 60.0 (57.1, 62.9) 37 (24, 45) 341 56.2
South Carolina 6 61.7 (60.1, 63.4) 31 (24, 39) 1,144 56.2
Iowa 3 71.7 (69.5, 74.0) 11 (5, 18) 816 56.0
California 3 58.4 (57.7, 59.0) 41 (36, 44) 7,221 55.8
Minnesota 6 61.7 (60.1, 63.3) 32 (24, 38) 1,180 55.6
Nebraska 6 71.7 (68.7, 74.7) 12 (3, 19) 459 55.6
Arizona 6 53.1 (51.9, 54.5) 48 (45, 49) 1,335 55.4
New York 3 63.2 (62.3, 64.0) 28 (23, 33) 4,401 55.4
Delaware 6 61.3 (57.7, 65.0) 33 (20, 45) 225 55.3
Kansas 6 65.8 (63.5, 68.1) 22 (16, 30) 649 55.3
West Virginia 6 75.0 (72.2, 77.9) 5 (2, 15) 558 55.1
Utah 3 45.9 (43.7, 48.2) 50 (49, 50) 346 55.0
Georgia 3 66.8 (65.5, 68.1) 20 (17, 24) 2,168 54.6
Massachusetts 3 55.0 (53.7, 56.3) 46 (42, 49) 1,350 54.6
Vermont 6 55.8 (51.7, 60.2) 44 (30, 49) 140 54.6
Oklahoma 6 67.1 (65.1, 69.1) 19 (15, 25) 894 54.3
Hawaii 3 62.9 (59.9, 66.1) 29 (19, 40) 337 54.1
Connecticut 3 55.7 (53.9, 57.5) 45 (40, 49) 754 53.9
Alabama 6 67.7 (65.9, 69.4) 18 (15, 24) 1,196 53.5
New Mexico 3 52.8 (50.5, 55.2) 49 (43, 49) 400 53.5
Kentucky 3 75.5 (73.6, 77.5) 4 (2, 10) 1,191 53.1
District of Columbia 6 53.6 (48.9, 58.6) 47 (34, 50) 100 51.0
Puerto Rico 6 15.8 (15.2, 16.3) N/A 697 46.6
Nevada 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 12/02/2022 1:32 am.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2021 submission.
3 Source: SEER November 2021 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2021 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2021 submission).

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top